Patent pools and clearinghouses in the life sciences

Esther Van Zimmeren; Sven Vanneste; Gert Matthijs; Wim Vanhaverbeke; Geertrui Van Overwalle

doi:10.1016/j.tibtech.2011.06.002

Patent pools and clearinghouses in the life sciences

Esther Van Zimmeren
, Sven Vanneste
, Gert Matthijs
, Wim Vanhaverbeke
, Geertrui Van Overwalle

Escuela Superior de Administración y Dirección de Empresas Esade

Producción científica: Artículo en revista indizada › Artículo › revisión exhaustiva

29 Citas (Scopus)

Resumen

The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences.

Idioma original	Inglés
Páginas (desde-hasta)	569-576
Publicación	Trends in Biotechnology
Volumen	29
N.º	11
DOI	https://doi.org/10.1016/j.tibtech.2011.06.002
Estado	Publicada - 1 nov 2011

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1016/j.tibtech.2011.06.002

Cómo citar

@article{c96c66e5ace448068a38719639686118,

title = "Patent pools and clearinghouses in the life sciences",

abstract = "The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences.",

author = "\{Van Zimmeren\}, Esther and Sven Vanneste and Gert Matthijs and Wim Vanhaverbeke and \{Van Overwalle\}, Geertrui",

year = "2011",

month = nov,

day = "1",

doi = "10.1016/j.tibtech.2011.06.002",

language = "English",

volume = "29",

pages = "569--576",

journal = "Trends in Biotechnology",

issn = "0167-7799",

publisher = "Elsevier Ltd.",

number = "11",

}

TY - JOUR

T1 - Patent pools and clearinghouses in the life sciences

AU - Van Zimmeren, Esther

AU - Vanneste, Sven

AU - Matthijs, Gert

AU - Vanhaverbeke, Wim

AU - Van Overwalle, Geertrui

PY - 2011/11/1

Y1 - 2011/11/1

N2 - The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences.

AB - The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences.

U2 - 10.1016/j.tibtech.2011.06.002

DO - 10.1016/j.tibtech.2011.06.002

M3 - Article

SN - 0167-7799

VL - 29

SP - 569

EP - 576

JO - Trends in Biotechnology

JF - Trends in Biotechnology

IS - 11

ER -

Patent pools and clearinghouses in the life sciences

Resumen

ODS de las Naciones Unidas

Acceder al documento

Huella

Cómo citar